TEC
NVRO

Tiger Eye Capital’s NEVRO CORP. NVRO Stock Holding History

Tiger Eye Capital’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,137
Closed -$254K – 59
2021
Q4 		$254K Hold
3,137
– – 0.07% 48
2021
Q3 		$365K Hold
3,137
– – 0.14% 41
2021
Q2 		$520K Hold
3,137
– – 0.13% 41
2021
Q1 		$438K Sell
3,137
-235,985
-99% -$38.5M 0.09% 50
2020
Q4 		$41.4M Buy
239,122
+93,969
+65% +$15.2M 7.28% 3
2020
Q3 		$20.2M Sell
145,153
-47,601
-25% -$6.36M 4.93% 8
2020
Q2 		$23M Buy
+192,754
New +$22.9M 5.46% 6
2020
Q1 		– Sell
-237,883
Closed -$28M – 56
2019
Q4 		$28M Sell
237,883
-13,244
-5% -$1.31M 4.96% 6
2019
Q3 		$21.6M Buy
251,127
+89,806
+56% +$6.8M 5.67% 6
2019
Q2 		$10.5M Buy
+161,321
New +$10M 2.18% 16

Other funds holding NVRO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Tiger Eye Capital's NVRO Position: Q1 2022 in Review

Tiger Eye Capital sold out of NEVRO CORP. (NVRO) in Q1 2022, closing a stake of 3,137 shares — an estimated $254K sold.

Tiger Eye Capital first reported a position in NVRO in Q2 2019 and held it in 10 quarters. The position peaked at $41.4M in Q4 2020. 195 funds tracked by Wall St. Rank hold NVRO as of Q1 2022.

  • Tiger Eye Capital reported no remaining NEVRO CORP. position as of Q1 2022 after selling out during the quarter.
  • Tiger Eye Capital sold 3,137 NEVRO CORP. shares in Q1 2022, an estimated $254K.
  • Tiger Eye Capital first reported a position in NEVRO CORP. in Q2 2019 and held it in 10 quarters.
  • Tiger Eye Capital's NEVRO CORP. position peaked at $41.4M in Q4 2020.
  • 195 funds tracked by Wall St. Rank held NEVRO CORP. as of Q1 2022.

Based on Tiger Eye Capital's 13F filing for Q1 2022, filed 16 May 2022.